Apellis Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Apellis Pharmaceuticals (NASDAQ:APLS) will present at the 44th Annual J.P.

Rhea-AI Summary

Apellis Pharmaceuticals (NASDAQ:APLS) will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 11:15 a.m. PT. The company said a live webcast of the presentation will be posted on the Events and Presentations page in its Investors and Media section. A replay will be available for approximately 90 days after the event.

Argus Jan 5 session

-3.83% close to close Open Argus

Details

News Market Reaction – APLS

In the Jan 5 session, APLS declined 3.83%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Apellis’ upcoming presentation at the 44th Annual J.P. Morgan Healthcar...

Analysis

This announcement highlights Apellis’ upcoming presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, with a webcast and a 90-day replay. It follows a series of significant updates, including strong Q3 2025 revenue of $458.6M and positive data for EMPAVELI and SYFOVRE. Historical reactions to conferences have been mixed, while clinical data often coincided with gains. Observers may focus on any incremental detail shared at the conference relative to these recent milestones.

Key Figures

Conference date: January 12, 2026 Presentation time: 11:15 a.m. PT Webcast replay period: 90 days

Conference date

January 12, 2026

Presentation at 44th Annual J.P. Morgan Healthcare Conference

Presentation time

11:15 a.m. PT

Scheduled time for J.P. Morgan conference presentation

Webcast replay period

90 days

Replay available after J.P. Morgan conference presentation

Historical Context

5 past events · Latest: Dec 03

5 events

1. Dec 03

   Phase 3 results

   24h Move

   +2.9%

   Positive Phase 3 VALIANT results for EMPAVELI in C3G and IC-MPGN.

2. Nov 25

   Investor conferences

   24h Move

   +4.3%

   Participation in Citi and Evercore healthcare investor conferences with webcasts.

3. Nov 12

   Clinical data update

   24h Move

   +2.6%

   Five-year GALE data showing SYFOVRE delayed GA progression by ~1.5 years.

4. Nov 05

   Investor conference

   24h Move

   -2.5%

   Announcement of a Stifel healthcare conference presentation and webcast replay.

5. Oct 30

   Earnings report

   24h Move

   -31.0%

   Q3 2025 results with $458.6M revenue and strong SYFOVRE/EMPAVELI performance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will present at the 44^th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 11:15 a.m. PT.

The live conference webcast will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcast will be available for approximately 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company leading the way in complement science to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two C3-targeting medicines approved to treat four serious diseases. Breakthroughs for patients include the first-ever therapy for geographic atrophy, a leading cause of blindness, and the first treatment for patients 12 and older with C3G or primary IC-MPGN, two severe, rare kidney diseases. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit http://apellis.com or follow us on LinkedIn and X.

Investor Contact: 
Eva Stroynowski
ir@apellis.com
617.938.6229

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Apellis Pharmaceuticals (APLS) presenting at the J.P. Morgan Healthcare Conference?

Apellis (APLS) is presenting on January 12, 2026 at 11:15 a.m. PT.

Where can investors watch the Apellis (APLS) live webcast for the January 12, 2026 presentation?

The live webcast will be posted on the company’s Events and Presentations page in the Investors and Media section.

How long will the replay of the Apellis (APLS) J.P. Morgan presentation be available?

A replay will be available for approximately 90 days following the event.

What time zone is the Apellis (APLS) presentation time listed in for January 12, 2026?

The presentation time is listed in Pacific Time (PT).

Will Apellis (APLS) provide materials or slides with the January 12, 2026 webcast?

The company indicated the live webcast will be posted on the Events and Presentations page; any accompanying slides or materials will be available there if provided.

How can I find the Apellis (APLS) webcast after the J.P. Morgan presentation ends?

Return to the company’s Events and Presentations page in the Investors and Media section to access the replay for about 90 days.